GLENMARK Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > glenmark

Technical Analysis

Technical Strength: 5.12 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 50.4. According to RSI analysis, glenmark is marginally weak. 4.0 GLENMARK RSI Chart
MACD (?) MACD: 0.476 and Signal Line: 1.57. According to MACD analysis, glenmark is marginally weak. 3.0 GLENMARK MACD Chart
Simple Moving Average (?) According to simple moving average analysis, glenmark is facing resistance from it's 20-day simple moving average at 487.6225 and support level is at 484. 8.0 GLENMARK Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 20-day exponential moving average which is a positive signal. According to exponential moving average analysis, glenmark is in a strong uptrend. Major support levels are 485.0906, 477.2083, 423.6027. 9.0 GLENMARK Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.407. 5.0 GLENMARK Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA GLENMARK Fibonacci Retracement Chart
Average True Range (?) ATR: 18.2 NA GLENMARK Average True Range Chart
Average Directional Index (?) ADX is 8.5 which means GLENMARK is in a trading range and there is no trend. NA GLENMARK Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 27, 2020
Open Price 478.9
High Price 486.5
Low Price 475.6
Close Price 485.2
Absolute Change 7.4
Percentage Change 1.55%
Weekly Change 0.56%
Monthly Change -2.1%
Yearly Change 56.1%
52-week high 573.05
52-week low 161.65
Corporate Actions
ExDate Purpose
September 17, 2020 AGM/DIV-RS 2.50 PER SH
September 19, 2019 AGM/DIV-RS 2 PER SH
September 19, 2018 AGM/DIV-RS 2 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.623
Confidence in Beta1.36%
Market Capital Rs. 13163.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 27 October 2020: Deliverable Quantity:3.26e+05 NA GLENMARK Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 27 October 2020: Daily Volatility:0.6305 NA GLENMARK Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 27 October 2020: PCR_OI:0.386 PCR:0.31 NA GLENMARK PCR Chart
Option Pain (?) 27 October 2020: Max Pain:480.0 NA GLENMARK Option Pain Chart
Premium (?) 27 October 2020 Premium: -0.7 Futures OI:2447200.0 NA GLENMARK Premium Chart
Option_MAX_OI (?) 27 October 2020: Price:485.2 Put with maximum OI:480.0 Call with maximum OI:500.0 NA GLENMARK Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
October 29, 2020 484.5 2447200.0 1962.0 1962.0 485.2
November 26, 2020 485.7 4450500.0 1370.0 1370.0 485.2
December 31, 2020 486.4 34500.0 3.0 3.0 485.2

Announcements

September 02, 2020 Book Closure Glenmark Pharmaceuticals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 19-Sep-2020 to 29-Sep-2020 for the purpose of Dividend.
October 01, 2018 Shareholders meeting Proceedings and Scrutinizer''s Report of the 40th Annual General Meeting {AGM) of Glenmark Pharmaceuticals Limited (''the Company'') held on September 28, 2018
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 06, 2020 August 14, 2020 Financial Results To consider and approve the financial results for the period ended Jun 30, 2020
June 18, 2020 June 26, 2020 Financial Results/Dividend To consider and approve the financial results for the period ended March 31, 2020 and dividend
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play